QED Projects

A focus of the Alliance is on research that has reached a stage where additional experiments will add significant value to the on-going research or facilitate the acquisition of data necessary for joint federal grant submissions or enhance the opportunities for another significant funding source.

Initial funding for the QED collaborative projects comes from Emory University, The University of Queensland, and QIMR Berghofer. As a guiding principle, the funds from each institution will be used to support the researchers from that institution when working in this collaborative context.

QED Project Award Winners 

QED Projects Round 1

The first call for QED Alliance funding went out in 2013. Funding opportunities included up to US $250,000 for major collaborative projects, as well as travel bursaries for either US $10,000 or US $5,000 to support researcher mobility.

US $250,000 awards for drug and vaccine development research

  • Breast cancer research project that is investigating how to block a cancer pathway responsible for poor prognosis in about 20 percent of breast cancer patients who are given existing cancer therapies.
    • Researchers: William Dynan and Haian Fu (Emory), Kum Kum Khanna (QIMR Berghofer) and David Fairlie (UQ)
    • Funding - US $250,000
  • Chronic cancer pain relief project investigating how to improve pain management outcomes and identified a lead compound with potential for development as a novel analgesic for the treatment of cancer-induced bone marrow pain.
    • Researchers: Dennis Liotta (Emory), Mark Goodman (Emory), Jeff Gorman (QIMR Berghofer) and Maree Smith (UQ)
    • Funding - US $250,000

Travel Bursaries – US $10,000 level awards

  • Matt Cooper, Lead (UQ), David Weiss, (Emory), David Reid (QIMR Berghofer)
    • Title - “Antibiotics Against Drug-Resistant Gram-Negative Bacteria”
  • Dennis Liotta, Lead (Emory), Matt Cooper, (UQ), David Harrich (QIMR Berghofer), Paul Young (UQ)
    • Title - “Development of Antiviral Compounds Targeting Dengue Virus”
  • Don McManus, Lead (QIMR Berghofer), Hong You (UQ), Istvan Toth (UQ), Francois Villinger (Emory), Siddappa Byrareddy (Emory)
    • Title - “An Achilles’ Heel Approach to Schistosome Vaccine Development”
  • Mark Walker, Lead (UQ), Istvan Toth (UQ), Peter Moyle (UQ), James McCarthy (QIMR Berghofer), Guido Silvestri (Emory), David Weiss (Emory)
    • Title - “Development and Immunological Evaluation of a Broadly-Protective Group A Streptococcal Vaccine, Incorporating Six Highly-Conserved Protective Antigens, in Non-Human Primates”
    • This project was awarded the highest-ranked development grant at the NHMRC Research Excellence Awards

Travel bursaries - US $5,000 level awards

  • Martin Moore, Lead (Emory), David Harrich (QIMR Berghofer), and Kirsten Spann (UQ)
    • Title - “Codon bias synthetic biology approach to develop live attenuated respiratory syncytial virus vaccines”
  • Andrew Jenkins (Emory) and Joe Lynch (UQ)
    • Title - “High throughput assay for biomarkers of and therapeutics for neurological disease”
  • William Lewis, Co-Lead (Emory), David Harrich, Co-Lead (QIMR Berghofer), Simon Phipps (UQ), and Andreas Suhrbier (QIMR Berghofer)
    • Title - "Novel therapy for chronic HIV: Effects on mitochondrial oxidative stress, agingand immune function”
  • Mehul Suthar, Lead (Emory) and Rajiv Khanna (QIMR Berghofer)
    • Title - “Exploiting innate immune responses to design a prophylactic vaccine for human cytomegalovirus”
  • Xiadong Cheng, Lead (Emory), George Muscat (UQ) and Jason Lee (QIMR) 
    • Title - “Exploring epigenetic inhibition in cancer and metabolic diseases”
  • Wayne Wang, Lead (Emory), David Paterson (UQ)
    • Title - “Antimicrobial Resistance Surveillance Study”

QED Projects Round 2

Research projects within brain health (neuroscience), cancer, and infectious diseases were priorities in Round 2, which took place in 2015. The goal is to facilitate the acquisition of data necessary for a joint federal grant submission or another significant funding source. Funding for second round projects was as follows:


  • Professor Marcus Meinzer (UQ); Professor Bruce Crosson (Emory); Professor Michael Breakspear (QIMRB)
    • Project: “Improving brain function in healthy and stroke populations by non-invasive brain stimulation”
    • Funds awarded - US $204,604
  • Professor Jason Lee (QIMRB); Professor Paul Vertino (Emory); Professor Lewis Perrin (UQ)
    • Project: "Targeting epigenetic modifying enzymes in aggressive cancers”
    • Funds awarded - US $174,754

Travel Bursaries

  • Mark Walker, Lead (UQ); Guido Silvestri, (Emory); James McCarthy, (QIMR Berghofer); Istvan Toth (UQ), Peter Moyle (UQ)
    • Project: “Evaluation of Immunological Efficacy and Safety Parameters of Experimental GAS vaccines in Non-Human Primates”
    • Funds awarded - US $14,500 
  • Irwin Waldman, Lead (Emory)
    • Project: “Gene-Based Tests of Genome-Wide Data on Externalizing Psychiatric Disorder Symptom Dimensions”
    • Funds awarded - US $5,000 
  • Professor Mark Schembri (UQ); Professor Alastair McEwan (UQ); Professor William Shafer (Emory); Professor Greg Anderson (QIMRB)
    • Project: “Cooper complexes as enhancers of antibiotic action against multi-drug resistant bacteria”
    • Funds awarded - US $30,000